HR 2041 United States House · 119th Congress

Hidden Fee Disclosure Act of 2025

The Hidden Fee Disclosure Act of 2025 requires pharmacy benefit managers and third-party administrators providing services to employee benefit plans to disclose detailed information about their compensation structures. Covered service providers must annually report all fees, rebates, discounts, and other financial arrangements they receive, including how much is retained versus passed through to the plan. This includes specific details about spread pricing, rebate handling, and compensation from drug manufacturers. The bill applies to all contracts entered into on or after January 1, 2026, and aims to increase transparency for plan fiduciaries managing employee health benefits.
Sub-Topics: Prescription Drugs
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
President
Introduced Mar 11, 2025 Last action Mar 11, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 11, 2025
Committee
Referred to the House Committee on Education and Workforce.
lower
Mar 11, 2025
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor

Sponsors